vs

Side-by-side financial comparison of MIMEDX GROUP, INC. (MDXG) and Texas Pacific Land Corporation (TPL). Click either name above to swap in a different company.

Texas Pacific Land Corporation is the larger business by last-quarter revenue ($211.6M vs $118.1M, roughly 1.8× MIMEDX GROUP, INC.). Texas Pacific Land Corporation runs the higher net margin — 58.3% vs 12.9%, a 45.4% gap on every dollar of revenue. On growth, MIMEDX GROUP, INC. posted the faster year-over-year revenue change (27.1% vs 13.9%). Over the past eight quarters, MIMEDX GROUP, INC.'s revenue compounded faster (18.1% CAGR vs 10.2%).

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

The Texas Pacific Land Corporation is a publicly traded real estate operating company with its administrative office in Dallas, Texas. Owning over 880,000 acres (3,600 km2) in 20 West Texas counties, TPL is among the largest private landowners in the state of Texas. It was previously organized as a publicly traded trust taxed as a corporation, and operated under the name Texas Pacific Land Trust.

MDXG vs TPL — Head-to-Head

Bigger by revenue
TPL
TPL
1.8× larger
TPL
$211.6M
$118.1M
MDXG
Growing faster (revenue YoY)
MDXG
MDXG
+13.2% gap
MDXG
27.1%
13.9%
TPL
Higher net margin
TPL
TPL
45.4% more per $
TPL
58.3%
12.9%
MDXG
Faster 2-yr revenue CAGR
MDXG
MDXG
Annualised
MDXG
18.1%
10.2%
TPL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDXG
MDXG
TPL
TPL
Revenue
$118.1M
$211.6M
Net Profit
$15.2M
$123.3M
Gross Margin
83.9%
Operating Margin
17.8%
70.5%
Net Margin
12.9%
58.3%
Revenue YoY
27.1%
13.9%
Net Profit YoY
104.2%
4.2%
EPS (diluted)
$0.10
$-8.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDXG
MDXG
TPL
TPL
Q4 25
$118.1M
$211.6M
Q3 25
$113.7M
$203.1M
Q2 25
$98.6M
$187.5M
Q1 25
$88.2M
$196.0M
Q4 24
$92.9M
$185.8M
Q3 24
$84.1M
$173.6M
Q2 24
$87.2M
$172.3M
Q1 24
$84.7M
$174.1M
Net Profit
MDXG
MDXG
TPL
TPL
Q4 25
$15.2M
$123.3M
Q3 25
$16.7M
$121.2M
Q2 25
$9.6M
$116.1M
Q1 25
$7.0M
$120.7M
Q4 24
$7.4M
$118.4M
Q3 24
$8.1M
$106.6M
Q2 24
$17.6M
$114.6M
Q1 24
$9.3M
$114.4M
Gross Margin
MDXG
MDXG
TPL
TPL
Q4 25
83.9%
Q3 25
83.5%
Q2 25
81.1%
Q1 25
81.2%
Q4 24
81.8%
Q3 24
81.8%
Q2 24
83.0%
Q1 24
84.7%
Operating Margin
MDXG
MDXG
TPL
TPL
Q4 25
17.8%
70.5%
Q3 25
19.5%
73.4%
Q2 25
12.5%
76.6%
Q1 25
9.4%
76.6%
Q4 24
11.9%
76.7%
Q3 24
13.3%
73.4%
Q2 24
26.9%
77.3%
Q1 24
15.6%
78.1%
Net Margin
MDXG
MDXG
TPL
TPL
Q4 25
12.9%
58.3%
Q3 25
14.7%
59.7%
Q2 25
9.8%
61.9%
Q1 25
8.0%
61.6%
Q4 24
8.0%
63.7%
Q3 24
9.6%
61.4%
Q2 24
20.2%
66.5%
Q1 24
10.9%
65.7%
EPS (diluted)
MDXG
MDXG
TPL
TPL
Q4 25
$0.10
$-8.59
Q3 25
$0.11
$5.27
Q2 25
$0.06
$5.05
Q1 25
$0.05
$5.24
Q4 24
$0.05
$5.14
Q3 24
$0.05
$4.63
Q2 24
$0.12
$4.98
Q1 24
$0.06
$4.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDXG
MDXG
TPL
TPL
Cash + ST InvestmentsLiquidity on hand
$166.1M
$144.8M
Total DebtLower is stronger
$18.0M
Stockholders' EquityBook value
$256.5M
$1.5B
Total Assets
$342.7M
$1.6B
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDXG
MDXG
TPL
TPL
Q4 25
$166.1M
$144.8M
Q3 25
$142.1M
$531.8M
Q2 25
$118.9M
$543.9M
Q1 25
$106.4M
$460.4M
Q4 24
$104.4M
$369.8M
Q3 24
$88.8M
$533.9M
Q2 24
$69.0M
$894.7M
Q1 24
$48.5M
$837.1M
Total Debt
MDXG
MDXG
TPL
TPL
Q4 25
$18.0M
Q3 25
Q2 25
Q1 25
Q4 24
$19.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MDXG
MDXG
TPL
TPL
Q4 25
$256.5M
$1.5B
Q3 25
$238.9M
$1.4B
Q2 25
$216.6M
$1.3B
Q1 25
$202.8M
$1.2B
Q4 24
$193.1M
$1.1B
Q3 24
$181.0M
$1.1B
Q2 24
$168.0M
$1.2B
Q1 24
$155.7M
$1.1B
Total Assets
MDXG
MDXG
TPL
TPL
Q4 25
$342.7M
$1.6B
Q3 25
$319.0M
$1.5B
Q2 25
$291.1M
$1.4B
Q1 25
$270.4M
$1.4B
Q4 24
$263.9M
$1.2B
Q3 24
$243.9M
$1.2B
Q2 24
$230.2M
$1.3B
Q1 24
$221.7M
$1.3B
Debt / Equity
MDXG
MDXG
TPL
TPL
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDXG
MDXG
TPL
TPL
Operating Cash FlowLast quarter
$25.0M
$113.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.64×
0.92×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDXG
MDXG
TPL
TPL
Q4 25
$25.0M
$113.7M
Q3 25
$29.3M
$154.6M
Q2 25
$14.4M
$120.9M
Q1 25
$5.3M
$156.7M
Q4 24
$18.8M
$126.6M
Q3 24
$19.6M
$118.6M
Q2 24
$21.8M
$98.3M
Q1 24
$6.0M
$147.2M
Cash Conversion
MDXG
MDXG
TPL
TPL
Q4 25
1.64×
0.92×
Q3 25
1.75×
1.28×
Q2 25
1.50×
1.04×
Q1 25
0.75×
1.30×
Q4 24
2.53×
1.07×
Q3 24
2.42×
1.11×
Q2 24
1.24×
0.86×
Q1 24
0.65×
1.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

TPL
TPL

Water Serviceand Operations Segment$98.2M46%
Water Sales And Royalties$60.7M29%
Produced Water Royalties$33.5M16%
Easementand Sundry$20.6M10%

Related Comparisons